In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on NeuroPace (NPCE – Research Report), with a price target of $20.00. The company’s shares closed last Friday at $11 ...
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But serious investors should think long and hard about avoiding extreme losses. So we ...
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...
J.P. Morgan analyst Robbie Marcus maintained a Buy rating on NeuroPace (NPCE – Research Report) on November 6 and set a price target of $9.00. The company’s shares closed yesterday at $7.07. Marcus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback